AI-generated summary
The authors prospectively followed 30 patients with hereditary hemorrhagic telangiectasia and treated nasal mucosal lesions with Nd:YAG laser at individually set intervals alongside ongoing nasal care. They report that no serious adverse effects were observed and that nosebleed frequency fell from several times daily to about every two weeks. The abstract describes this as a proven and effective regimen, but the study has no control group and was a single-arm prospective case series.
- Participants
- 30
- Who or what was studied
- Patients with hereditary hemorrhagic telangiectasia (HHT) with recurrent epistaxis
- Limits stated in the abstract
- The abstract describes a prospective series of 30 patients without a control group, so the reported benefit cannot be attributed to the laser alone.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.